Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -26.33x is 96% above its 4-year average of -605.15x, near the high end of its 4-year range (-3075.00x–4.81x).
69.94% above its 12-month average of -87.59x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -31.04x.
INTEREST COVERAGE RATIO
-26.33x
INTEREST COVERAGE RATIO AVG TTM
-87.59x
INTEREST COVERAGE RATIO AVG 3Y
-62.91x
INTEREST COVERAGE RATIO AVG 5Y
-605.15x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+69.94%
CURRENT VS 3Y AVG
+58.15%
CURRENT VS 5Y AVG
+95.65%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-313.02%
vs the sector median at left
Opus Genetics, Inc.
Market Cap
$361.64M
Interest Coverage Ratio
-26.33x
TTM Avg
-87.59x
3Y Avg
-62.91x
5Y Avg
-605.15x
Market Cap
$359.53M
Interest Coverage Ratio
-3.05x
TTM Avg
0.61x
3Y Avg
0.61x
5Y Avg
0.61x
Market Cap
$355.43M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$355.36M
Interest Coverage Ratio
17.52x
TTM Avg
20.30x
3Y Avg
29.07x
5Y Avg
34.22x
Market Cap
$353.88M
Interest Coverage Ratio
-11.11x
TTM Avg
316.78x
3Y Avg
4209.35x
5Y Avg
3030.57x
Market Cap
$369.50M
Interest Coverage Ratio
N/A
TTM Avg
4.06x
3Y Avg
4.06x
5Y Avg
4.06x
Market Cap
$353.00M
Interest Coverage Ratio
3.07x
TTM Avg
2.31x
3Y Avg
3.74x
5Y Avg
3.74x
Market Cap
$352.67M
Interest Coverage Ratio
-12.13x
TTM Avg
372.18x
3Y Avg
320.22x
5Y Avg
320.22x
Market Cap
$349.70M
Interest Coverage Ratio
-45.13x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Opus Genetics, Inc. (IRD) | $361.64M | -26.33x | -87.59x | -62.91x | -605.15x |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | -3.05x | 0.61x | 0.61x | 0.61x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | N/A | N/A | N/A | N/A |
| Viemed Healthcare, Inc. (VMD)vs › | $355.36M | 17.52x | 20.30x | 29.07x | 34.22x |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.88M | -11.11x | 316.78x | 4209.35x | 3030.57x |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $369.50M | N/A | 4.06x | 4.06x | 4.06x |
| Embecta Corp. (EMBC)vs › | $353.00M | 3.07x | 2.31x | 3.74x | 3.74x |
| Ocugen, Inc. (OCGN)vs › | $352.67M | -12.13x | 372.18x | 320.22x | 320.22x |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.70M | -45.13x | N/A | N/A | N/A |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $374.50M | -347.29x | N/A | N/A | N/A |
Interest Coverage
-26.3x
Debt/Equity
N/A
Current Ratio
12.19
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -31.04x |
| 2026-03-31 | -22.06x |
| 2025-12-31 | -8.19x |
| 2025-09-30 | -122.22x |
| 2025-06-30 | -254.46x |
| 2025-03-31 | -7.24x |
| 2023-09-30 | 4.81x |
| 2022-06-30 | -1234.50x |
| 2022-03-31 | -1301.60x |
| 2021-12-31 | -3075.00x |
| 2020-12-31 | -2.58x |
| 2020-09-30 | -10.88x |
| 2020-06-30 | -1.83x |
| 2020-03-31 | -4.94x |
